Review: Early treatment of a cardiovascular event with nitrates or ACE inhibitors reduces short-term mortality
- A decline in coronary mortality. // British Medical Journal;1/10/1976, Vol. 1 Issue 6001, p58
Presents results of the research on mortality from ischemic heart disease in the United States and Australia. Changes made in diagnostic accuracy, death certification and classification; Efforts to increase public awareness of the dangers of tobacco and overeating; Benefits of physical exercise.
- Review: Drug-eluting stents for coronary artery disease do not reduce mortality more than bare-metal stents. Nordmann, A. J.; Briel, M.; Bucher, H. C. // ACP Journal Club;May/Jun2007, Vol. 146 Issue 3, p66
The article examines a study which compares the effectiveness of drug-eluting (DES) stents versus bare metal stents (BMS) in treating patients with coronary artery disease. Results revealed that DES and BMS did not differ in terms of total mortality or cardiac mortality at any follow-up...
- Review: Drug-eluting stents for coronary artery disease do not reduce mortality more than bare-metal stents: COMMENTARY. Bates, Eric R. // ACP Journal Club;May/Jun2007, Vol. 146 Issue 3, p66
The author comments on a study which compares the effectiveness of drug-eluting (DES) stents versus bare metal stents (BMS) in patients with coronary artery disease. He asserted that the meta-analysis by researchers used to support DES labeling has indicated no long-term increase in death of...
- Drug-eluting stents increased risk for late cardiac death or myocardial infarction more than bare-metal stents. Pfisterer, M.; Brunner-La Rocca, H. P.; Buser, P. T. // ACP Journal Club;May/Jun2007, Vol. 146 Issue 3, p67
The article presents a study which examines the effectiveness of drug-eluting stents (DES) versus bare-metal stents (BMS) in patients with coronary artery disease who discontinue anti-platelet therapy. Results revealed that DES lessen the risk of having major cardiac events. It is concluded that...
- Stalin use among healthy patients can halve deaths. Tanday, Sanjay // GP: General Practitioner;2/13/2009, p7
The article reports on the outcomes of a study which examines the benefits of using statin therapy. The study shows that long-term use of statin therapy could reduce the risk of all-cause mortality among patients who have yet to develop coronary heart disease (CHD). It suggests greater use of...
- DES show mortality benefit in AMI. Lindsay, Alistair C.; Qureshi, Katie // Heart;Jan2009, Vol. 95 Issue 1, p93
The article reports on the study about drug-eluting stents (DES), which shows mortality benefit in acute myocardial infarction (AMI). The study was based on an unselected, population based cohort of 7217 patients undergoing PCI with stenting for AMI over an 18-month period in Massachusetts...
- Managing coronaries at home. // British Medical Journal;6/16/1979, Vol. 1 Issue 6178, p1586
Reports the proposals to provide intensive coronary care to a patient's home. Development of coronary care units; Increase of the mortality rate associated with coronary heart diseases; Effectiveness of lignocaine.
- Atorvastatin reduced coronary and stroke events in patients
with hypertension and without dyslipidemia. // ACP Journal Club;Nov/Dec2003, Vol. 139 Issue 3, p57
This article discusses efficacy of atorvastatin for primary prevention of coronary heart disease (CHD) in patients with hypertension and no dyslipidemia. Primary outcome was the combined endpoint of nonfatal myocardial infarcation (MI) and fatal CHD. Secondary endpoints were the primary outcome...
- Changing mortality from ischaemic heart disease in Great Britain 1968-76. du V Florey, C.; Melia, R.J.W.; Darby, S.C. // British Medical Journal;3/11/1978, Vol. 1 Issue 6113, p635
Reports the increase in mortality rates caused by ischemic heart disease (IHD) in Great Britain. Relation between tobacco consumption and IHD death rates; Influence of diet on the incidence of IHD; Significance of changing life styles in preventing IHD.